Dr. Bamat’s research interest is neonatal respiratory failure, with an emphasis on pharmacotherapies for severe bronchopulmonary dysplasia and continuous distending airway pressure levels in infants requiring respiratory support.
Dr. Foglia's research aims to identify the best methods to monitor and perform neonatal resuscitation, with the ultimate goal of optimizing outcomes for high risk infants who require resuscitation in the delivery room and neonatal intensive care unit setting.
Dr. Lorch's research involves understanding the root causes for variations in health outcomes and healthcare utilization experienced by high-risk children, particularly those born prematurely. He is particularly interested in the role of local and state policies on the observed variation in outcomes of premature infants, such as the impact of certificate of need programs on such outcomes.
Dr. Hurt is interested in the effects of maternal substance use on the immediate and long-term outcome of children, understanding poverty and other complex factors that affect the lives of inner-city children, and neonatal outcomes.
Dr. Conine works to understand the functions of small RNAs in reproduction, epigenetic inheritance, and development. His research focuses on how small RNAs in sperm transmit epigenetic information to offspring, as well as their involvement in male fertility.
The principal goal of Dr. Simmons' research program is to elucidate the underlying molecular mechanisms that link an aberrant intrauterine milieu to the later development of diseases in adulthood. She has made many seminal contributions to the understanding of the role that epigenetic modifications play in developmental programming of obesity and type 2 diabetes.
Dr. Eichenwald's research interests include clinical trials and quality improvement in neonatal-perinatal medicine. He has extensive experience in the conduct of multicenter clinical trials, having served as a site principal investigator for several funded, multicenter randomized trials of interventions aimed at improving outcomes of premature newborns.
Dr. Worthen's research program focuses on the mechanisms of acute inflammation in the lung. For more than 30 years he has worked to develop concepts, tools, and approaches to understand how neutrophils are mobilized from the bone marrow, retained within pulmonary capillaries, and migrate into the lung parenchyma and airspaces.
Dr. Ischiropoulos's research objectives are to develop and test novel therapeutics for long-chain fatty acid oxidation (LCFA) disorders, a collection of inherited metabolic diseases that affect the heart, liver and muscle. A second area of interest is the resolution of the nitric oxide signaling pathways at the proteome level in the cardiovascular and neuronal systems.